Same-day discharge following minimally invasive partial and radical nephrectomy: a National Surgical Quality

Krishna Teja Ravivarapu1, Evan Garden1, Chih Peng Chin1

  • 1Department of Urology, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1272, New York, NY, 10029, USA.

Abstract

Insights

Same-day discharge (SDD) after minimally invasive partial nephrectomy (MIPN) and radical nephrectomy (MIRN) is safe. Patients undergoing SDD experienced no increased risk of complications, reoperation, or readmission compared to standard-length discharge (SLD).

Area of Science:

  • Urology
  • Surgical Outcomes
  • Health Services Research

Background:

  • Minimally invasive partial nephrectomy (MIPN) and minimally invasive radical nephrectomy (MIRN) are standard procedures.
  • Shorter length of stay (LOS) is a goal in surgical care.
  • Same-day discharge (SDD) is being explored as a strategy to reduce LOS.

Purpose of the Study:

  • To compare 30-day outcomes for same-day discharge (SDD) versus standard-length discharge (SLD) after MIPN and MIRN.
  • To evaluate the safety and efficacy of SDD in a national cohort.

Main Methods:

  • A national cohort of 28,140 patients undergoing MIPN or MIRN from 2012-2019 was analyzed.
  • Patients were divided into SDD (LOS=0) and SLD (LOS=1-3) groups.
  • 1:1 matching was performed based on demographics and comorbidities, followed by comparison of 30-day complications, reoperations, and readmissions using multivariable logistic regression.

Main Results:

  • No significant differences were found in 30-day readmissions or Clavien-Dindo complications (I-IV) between SDD and SLD groups post-matching.
  • Multivariate analysis confirmed that SDD did not increase the risk of 30-day complications or readmissions for either MIPN or MIRN.

Conclusions:

  • Same-day discharge following MIPN and MIRN is a safe option.
  • SDD does not lead to increased postoperative complications, reoperations, or readmissions compared to standard-length discharge.
  • Further research is needed to identify optimal patient selection criteria for expanding SDD initiatives.